揭示聚C结合蛋白2作为色素C的标蛋白,用于预防前列腺癌:通过基于点击化学活动的蛋白质组学分析方法验证机制
Lan Huang1, Buqing Ma1, Chong Zhang1
1School of medicine, Huaqiao University, Quanzhou, 362021, China.
BMC cancer
|October 9, 2023
概括
库尔库森C的向是聚基结合蛋白2 (PCBP2) 以诱导前列腺癌细胞的亡. 这种化合物可能通过破坏Bax/Bcl-2平衡和线粒体通路来提供一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于当前治疗方法的局限性,包括低选择性和高毒性,前列腺癌存在重大治疗挑战.
- 不明确的药物点导致现有的前列腺癌治疗方法的无效和不良影响.
研究的目的:
- 为了确定Curcusone C的特定蛋白质标,Curcusone C是一种具有潜在抗前列腺癌活性的化合物.
- 阐明Curcusone C发挥抗癌作用的作用机制.
主要方法:
- 使用基于化学活动的蛋白质组分析 (CC-ABPP) 来识别目标蛋白质.
- 使用竞争性CC-ABPP,药物亲和度响应目标稳定性 (DARTS) 和表面等离子体共振 (SPR) 进行了目标验证.
- 作用机制通过体外西部斑点和体内研究评估,包括HE染色,TUNEL试验和IHC.
主要成果:
- 鉴定出多C结合蛋白2 (PCBP2) 是Curcusone C. 的直接标蛋白.
- 曲素C抑制了PCBP2的表达,导致PC-3细胞中Bax/Bcl-2平衡的破坏.
- 这种抑制会诱导线粒体损伤,激活线粒体亡途径,并促进前列腺癌细胞死亡.
结论:
- 库尔库森C通过准PCBP2.2,显示出作为抗前列腺癌药物的潜力.
- 该化合物的机制涉及调节Bax/Bcl-2平衡,并可能影响TGF/Smad信号通路.
- 这些发现为Curcusone C用于前列腺癌治疗的临床开发提供了基础.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
Cooperative Binding of Transcription Regulators
6.5K
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
6.5K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Directing Proteins to the Rough Endoplasmic Reticulum
7.3K
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
7.3K


